Metastatic

Type: Keyphrase
Name: Metastatic
First reported 17 mins ago - Updated 17 mins ago - 1 reports

Methylated DNA Blood Test Monitors Breast Cancer Progress and Treatment Response

Image: The Infinium HumanMethylation27 BeadChip Kit uses the Infinium Methylation Assay and is compatible with the iScan, HiScan, and Bead Array Reader systems (Photo courtesy of Illumina).An advanced assay that measures DNA hypermethylatation in blood ... [Published Lab Medica - 17 mins ago]
First reported 52 mins ago - Updated 52 mins ago - 1 reports

Jason's four-year melanoma fight

Jason Johnston has been fighting metastastic melanoma for four years despite a recent terminal diagnosis.FOUR years ago Devonport resident Jason Johnston began to get frequent blood noses and a niggling discomfort in his sinus area.After going to see ... [Published Northwest Tasmania Advocate - 52 mins ago]
First reported 1 hour ago - Updated 1 hour ago - 1 reports

Wholeexome sequencing of circulating tumor cells provides a window into metastatic prostate cancer

Related Biotechnology, Pharmaceutical and Healthcare NewsWhole-exome sequencing of circulating tumor cells enables accurate and powered calling of somatic point mutations.Original Article: Whole-exome sequencing of circulating tumor cells provides a window ... [Published BioPortfolio - 1 hour ago]
First reported 22 hours ago - Updated 22 hours ago - 1 reports

500,000 ‘likely to die’ of cancer this year

LAHORE Up to 500,000 people are likely to die of cancer diseases in 2014 in Pakistan if timely treatment is not provided to them.President of Surgical Oncology Society of Pakistan Dr Arshad Cheema said at the Lahore Press Club on Saturday the figures ... [Published Oman Tribune - 22 hours ago]
First reported Apr 18 2014 - Updated Apr 19 2014 - 2 reports

Trial updates on injectable oncolytic immunotherapy for metastatic melanoma

NEW YORK — Robert H.I. Andtbacka, MD, CM, FACS, FRCSC , highlights the contrasting results from the two completed phase 3 trials involving velimogene aliplasmid and talimogene laherparepvec.Andtbacka reviewed data demonstrating that velimogene aliplasmid ... [Published Orthopedics Today - Apr 19 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 2 reports

New blood test 95% accurate at detecting cancer recurrence

Approximately one in five survivors of breast cancer, who underwent 5 years of chemotherapy and/or radiation, end up having a recurrence within 10 years. And, now, a new blood test has been developed that researchers say is 95 percent accurate in detecting ... [Published EMax Health - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Longterm survivor characteristics in HER2positive metastatic breast cancer from registHER

Related Biotechnology, Pharmaceutical and Healthcare NewsOriginal Article: Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHERNEXT ARTICLE More From BioPortfolio on "Long-term survivor characteristics in HER2-positive ... [Published BioPortfolio - Apr 18 2014]
First reported Apr 16 2014 - Updated Apr 17 2014 - 2 reports

Palliative Radiotherapy for Prostate Cancer

ABSTRACT: Radiotherapy is an effective tool for the palliation of symptoms commonly caused by prostate cancer. The majority of painful bone metastases respond equally well to single or multiple fractions of external radiotherapy. Retreatment with a second ... [Published Consultant Live - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 2 reports

INCYTE - JAKAFI’s Label Expansion in Ref. Metastatic Pancreatic Cancer = Multi-Billion Potential! - new market research report published

- INCYTE - JAKAFIâs Label Expansion in Ref. Metastatic Pancreatic Cancer = Multi-Billion Potential! - a new market research report on companiesandmarkets.comPositive interim Overall Survival analysis data from the PhII, RECAP trial of Ruxolitinib (L â ... [Published PR inside - Apr 17 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 4 reports

New blood test 'accurately predicts breast cancer recurrence'

Around 1 in 5 breast cancer survivors who have undergone 5 years of therapy experience cancer recurrence within the following 10 years, according to a 2008 study. Now, researchers from the Johns Hopkins Kimmel Cancer Center in Baltimore, MD, have created ... [Published Medical News Today - Apr 15 2014]
Entities: Breast Cancer, Cancer, Assay
First reported Apr 14 2014 - Updated Apr 15 2014 - 2 reports

NeoStem to acquire California Stem Cell, expanding pipeline14-04-2014

USA-based NeoStem (NYSE Amex: NBS) has entered into a definitive agreement to acquire California Stem Cell (CSC), an Irvine, California-based stem cell biotechnology company in a stock and potential cash deal.The merger accord provides for the issue of ... [Published Pharma Letter - Apr 14 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 2 reports

Bayer Starts Phase III Trials With Radium Dichloride For Prostate Cancer

Bayer Health Care has started an international Phase III trial program with radium 223 dichloride, already approved in Europe and the U.S. as Xofigo (Ra223), for the treatment of metastatic castration-resistant prostate cancer in patients who have no ... [Published BioPortfolio - Apr 15 2014]

Quotes

...Saraswati Sukumar, professor of oncology at Johns Hopkins University. "Our assay shows great potential for development as a clinical laboratory test for monitoring therapy and disease progression and recurrence. If it is determined early that a treatment is not working, clinicians can save time and switch to a different therapy."
NEXT ARTICLE More From BioPortfolio on "Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer"
...is that the market believes that cabozantinib will have trouble competing against more established prostate cancer drugs like Johnson & Johnson "s Zytiga without strong evidence that the drug has a stellar efficacy profile. Indeed, the prostate cancercancer drug market has seen a number of newcomers of late, some of whom have struggled in this crowded space. That said, I believe Exelixis is now a bargain following this dramatic sell-off and is set to rebound. My thinking is simple: Some of the worst-selling prostate cancer drugs still see sales in the hundreds of millions and Exelixis" market cap has fallen to a mere $600 million...
...Robert J Lewandowski, MD, associate professorprofessor of radiology at Northwestern University Feinberg School of Medicine in Chicago, Illinois. "The treatment is not limited by tumor size, shape, location, or number.”"

More Content

All (2101) | News (1875) | Reports (0) | Blogs (189) | Audio/Video (0) | Fact Sheets (2) | Press Releases (22)
sort by: Date | Relevance
Methylated DNA Blood Test Monitors Breast Cance... [Published Lab Medica - 17 mins ago]
Jason's four-year melanoma fight [Published Northwest Tasmania Advocate - 52 mins ago]
Wholeexome sequencing of circulating tumor cell... [Published BioPortfolio - 1 hour ago]
Verastem: Cancer May Have Met Its Match [Published Seeking Alpha - 12 hours ago]
500,000 ‘likely to die’ of cancer this year [Published Oman Tribune - 22 hours ago]
This Marathon something special [Published Boston Globe - Apr 20 2014]
Komen Chronicles Of Hope: 23-year breast cancer... [Published Tyler Morning Telegraph - Apr 20 2014]
Nektar Presents Pipeline Data - Analyst Blog [Published Mr Top Step - Apr 19 2014]
Cancer event for sufferers and families [Published Alloa & Hillfoots Advertiser - Apr 19 2014]
Inside bra is no place for a pedometer [Published Buffalo News - Apr 19 2014]
Trial updates on injectable oncolytic immunothe... [Published Orthopedics Today - Apr 19 2014]
1 of These 3 Cratering Biotechs is a Buy [Published Motley Fool Discussion Boards - Apr 18 2014]
How Big Is the Threat to This Johnson & Johnson... [Published Motley Fool Discussion Boards - Apr 18 2014]
New blood test 95% accurate at detecting cancer... [Published EMax Health - Apr 18 2014]
Longterm survivor characteristics in HER2positi... [Published BioPortfolio - Apr 18 2014]
Y-90 radioembolization: A new treatment for hep... [Published Chemotherapy Advisor - Apr 18 2014]
Measurement of Protein Kinase B Activity in Sin... [Published Analytical Chemistry - Apr 18 2014]
CD44 variant 6 is associated with prostate canc... [Published UroToday - Apr 18 2014]
Improving the biodistribution of PSMA-targeting... [Published UroToday - Apr 18 2014]
Durable T-VEC Responses Fail to Prolong Surviva... [Published OncLive - Apr 18 2014]
The Metabolic Drug-drug Interaction Profile of ... [Published Drug Metabolism And Disposition - Apr 18 2014]
Benaroya Research Institute Evaluates Immunolog... [Published Infrosoft - Apr 18 2014]
Blood Test Predicts Breast Cancer Recurrence [Published Cancernetwork.com - Apr 18 2014]
Benaroya Research Institute Evaluates Immunolog... [Published Newswise - Apr 18 2014]
Androgen receptor antagonists for prostate canc... [Published UroToday - Apr 18 2014]
OBITUARY: Robert "Bob" Sayre [Published Iowa City Patch - Apr 18 2014]
Cancer Today Magazine Spring Issue Highlights I... [Published American Association for Cancer Research - Apr 18 2014]
Glycotope enrolls and treats first patients in ... [Published Individual.com - Apr 18 2014]
Cohen’s Point72 Asset Management buys a stake i... [Published Yahoo! Finance - Apr 18 2014]
Doxorubicin-ifosfamide combo improves progressi... [Published Chemotherapy Advisor - Apr 18 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
In nature, death is not defeat [Published 3quarksdaily - Apr 17 2014]
Eva Saulitis in Orion Magazine: FOR TWENTY-SIX SEPTEMBERS I’ve hiked up streams littered with corpses of dying humpbacked salmon. It is nothing new, nothing surprising, not the stench, not the gore, not the thrashing of black humpies plowing past ...
Patients, doctors embracing alternative medicin... [Published ScienceBlogs : Combined Feed - Apr 15 2014]
In the well over nine years that I’ve been blogging, there’s one tried and true, completely reliable topic to blog about, one that I can almost always find. I’m referring, of course, to the credulous news story about pseudoscience. The pseudoscience ...
Trinidad & Tobago Ministry of Health approves J... [Published PBR - News - Apr 14 2014]
The Chemistry, Food & Drugs Division of the Trinidad & Tobago Ministry of Health has approved the introduction of Janssen's Abiraterone Acetate in the country for the treatment of patients with metastatic castration-resistant prostate cancer. ...
Column: The Legacy of Obama's Illegal Alien Aunt [Published NewsBusters.org blogs - Apr 11 2014]
Zeituni Onyango, President Obama's illegal alien aunt, died this week of cancer and other complications. I hope she rests in peace. America, however, should be up in arms. Auntie Zeituni is an enduring symbol of all that is wrong with this country's ...
The Legacy of Obama's Illegal Alien Aunt Zeituni [Published Cleveland Tea Party Patriots - Apr 11 2014]
From Michelle Malkin via Townhall -- Zeituni Onyango, President Obama's illegal alien aunt, died this week of cancer and other complications. I hope she rests in peace. America, however, should be up in arms.Auntie Zeituni is an enduring symbol of ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Lion Biotechnologies' Lead Program With Nationa... [Published GlobeNewswire: Advertising News - Apr 07 2014]
Immunicum submits the final report for its phas... [Published GlobeNewswire: Acquisitions News - Mar 31 2014]
Immunicum’s abstract with data from a kidney ca... [Published GlobeNewswire: Acquisitions News - Mar 27 2014]
Cometriq® approved in Europe for the treatment ... [Published GlobeNewswire: Acquisitions News - Mar 25 2014]
Delcath Systems Analyst Report by BrokerBank Se... [Published Financial Services - Mar 24 2014]
1 2 3 4 5
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.